Anthera Pharmaceuticals, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Paul F. Truex
IPO Date
2010-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.02M
| -0.5 |
| 31 Dec 2015 | FY | 99.0% | -1096.1% | -88.0% | -72.5% | 0.00 | 5.65 | -4.7 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 1340.5% | -868.5% | 0.00 | 0.53 | -1.1 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -224.3% | -88.5% | 1.21 | 3.48 | -1.7 |
| 31 Dec 2012 | FY | 0.0% | 0.0% | 1684.6% | -224.6% | -5.83 | 2.63 | -0.6 |
| 31 Dec 2011 | FY | 0.0% | 0.0% | -499.6% | -137.2% | 1.27 | 2.25 | -2.4 |
| 31 Dec 2010 | FY | 0.0% | 0.0% | -70.6% | -61.9% | 0.00 | 8.15 | -2.8 |
| 31 Dec 2009 | FY | 0.0% | 0.0% | 99.4% | -207.2% | -1.07 | 0.21 | -0.9 |
| 31 Dec 2008 | FY | 0.0% | 0.0% | 3932.4% | -225.3% | 0.00 | 0.94 | -0.6 |
| -0.6 |
| 30 Sept 2017 | Q3 | 0.0% | 0.0% | -1358.3% | -55.7% | 0.00 | 1.53 | -0.8 |
| 30 Jun 2017 | Q2 | 0.0% | 0.0% | 203.7% | 64.0% | 0.00 | 3.28 | 0.4 |
| 31 Mar 2017 | Q1 | 0.0% | 0.0% | -490.8% | -49.6% | 0.00 | 3.73 | -0.5 |
| 31 Dec 2016 | Q4 | 0.0% | 0.0% | -104.1% | -55.3% | 0.00 | 2.14 | -0.5 |
| 30 Sept 2016 | Q3 | 0.0% | 0.0% | -146.7% | -47.8% | 0.00 | 2.38 | -2.0 |
| 30 Jun 2016 | Q2 | 0.0% | 0.0% | -69.8% | -46.7% | 0.00 | 2.94 | -2.2 |
| 31 Mar 2016 | Q1 | 93.4% | -8086.9% | -38.0% | -30.2% | 0.00 | 4.81 | -3.1 |
| 31 Dec 2015 | Q4 | 99.6% | -382.6% | -18.5% | -15.2% | 0.00 | 5.65 | -6.3 |